MACULAR DEGENERATION TREATMENT MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026 - 2033)

Macular Degeneration Treatment Market, By Type (Dry Age-related Macular Degeneration and Wet Age-related Macular Degeneration), By Stage Of Disease (Early-stage AMD, Intermediate AMD, Late-stage AMD), By Route Of Administration (Intravenous Route and Intravitreal Route), By Sales Channel (Ambulatory Surgical Centres, Hospitals, and Other Sales Channels), By Geography (North America, Europe, Asia-Pacific, Latin America, and Middle East & Africa)

Published In: 18 Mar, 2026
Code: CMI5149
Page number: 152
Formats: Excel and PDF
Industry: Pharmaceutical
- Historical Range : 2020 - 2024
- Base Year : 2025
- Estimated Year : 2026
- Forecast Period : 2026 - 2033

Table of Contents (Version-2026)

Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
Market Purview
- Report Description
  - Market Definition and Scope
- Executive Summary
  - Market Snapshot, By Type
  - Market Snapshot, By Stage of Disease
  - Market Snapshot, By Route of Administration
  - Market Snapshot, By Sales Channel
  - Market Snapshot, By Geography
- Coherent Opportunity Map (COM)
Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
  - Increasing burden of retinal disorders worldwide
  - Lack of awareness regarding macular degeneration
  - Increasing demand for safe and effective treatment
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER’s Analysis
- Merger and Acquisition Scenario
Macular Degeneration Treatment Market, By Type, 2026-2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2025, 2028, and 2033 (%)
  - Y-o-Y Growth Analysis, 2021-2033
  - Segment Trends
- Dry Age-related Macular Degeneration
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
- Wet Age-related Macular Degeneration
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
Macular Degeneration Treatment Market, By Stage of Disease, 2026-2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2025, 2028, and 2033 (%)
  - Y-o-Y Growth Analysis, 2021-2033
  - Segment Trends
- Early-stage AMD
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
- Intermediate AMD
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
- Late-stage AMD
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
Macular Degeneration Treatment Market, By Route of Administration, 2026-2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2025, 2028, and 2033 (%)
  - Y-o-Y Growth Analysis, 2021-2033
  - Segment Trends
- Intravenous Route
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
- Intravitreal Route
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
Macular Degeneration Treatment Market, By Sales Channel, 2026-2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2025, 2028, and 2033 (%)
  - Y-o-Y Growth Analysis, 2021-2033
  - Segment Trends
- Ambulatory Surgical Centres
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
- Hospitals
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
- Other Sales Channels
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, 2021-2033,(USD Bn)
Macular Degeneration Treatment Market, By Geography, 2026-2033, (USD Bn)
- Introduction
  - Market Share Analysis, 2025, 2028, and 2033 (%)
  - Y-o-Y Growth Analysis, 2021-2033
  - Segment Trends
- North America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033,(USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Stage of Diseases, 2026-2033,(USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033,(USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2026-2033,(USD Bn)
  - Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    - U.S.
    - Canada
- Europe
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033,(USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Stage of Diseases, 2026-2033,(USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033,(USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2026-2033,(USD Bn)
  - Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    - U.K.
    - Germany
    - Italy
    - France
    - Spain
    - Russia
    - Rest of Europe
- Asia Pacific
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033,(USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Stage of Diseases, 2026-2033,(USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033,(USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2026-2033,(USD Bn)
  - Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    - China
    - India
    - Japan
    - ASEAN
    - Australia
    - South Korea
    - Rest of Asia Pacific
- Latin America
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033,(USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Stage of Diseases, 2026-2033,(USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033,(USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2026-2033,(USD Bn)
  - Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    - Brazil
    - Argentina
    - Mexico
    - Rest of Latin America
- Middle East and Africa
  - Introduction
  - Market Size and Forecast, and Y-o-Y Growth, By Type, 2026-2033,(USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Stage of Diseases, 2026-2033,(USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2026-2033,(USD Bn)
  - Market Size and Forecast, and Y-o-Y Growth, By Sales Channel, 2026-2033,(USD Bn)
  - Market Size and Forecast, By Country, 2026- 2033, (USD Bn)
    - GCC Countries
    - Israel
    - Rest of Middle East
    - South Africa
    - North Africa
    - Central Africa
Competitive Landscape
- Bayer AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- REGENXBIO Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Aerie Pharmaceutical Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Panoptica
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Pfizer Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Hoffmann-La Roche Ltd.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Regeneron Pharmaceutical Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Novartis AG
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Bausch Health Companies Inc.
  - Company Highlights
  - Product Portfolio
  - Key Developments
  - Financial Performance
  - Strategies
- Analyst Views
Section
- Research Methodology
- About us

Get Instant Access - Buy Now

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports
Customize Now